Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
China flag China · Delayed Price · Currency is CNY
27.14
+0.11 (0.41%)
Apr 30, 2026, 3:00 PM CST

SHA:603351 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,3421,3351,2871,1521,1031,032
Other Revenue
--9.944.218.3610.24
1,3421,3351,2971,1561,1111,042
Revenue Growth (YoY)
1.90%2.95%12.19%4.04%6.59%41.60%
Cost of Revenue
954.77955.04938.49842.97810.66762.68
Gross Profit
386.85380358.26312.87300.36279.63
Selling, General & Admin
115.68113.9115.84121.5126.32107.53
Research & Development
82.4381.5371.5655.6453.8740.73
Other Operating Expenses
-3.28-2.961.253.237.66.77
Operating Expenses
194.83192.47188.99180.67183.31157.17
Operating Income
192.02187.53169.27132.2117.04122.46
Interest Expense
---13.84-15.25-12.48-7.04
Interest & Investment Income
0.020.020.930.780.631.47
Currency Exchange Gain (Loss)
--1.540.532.48-0.51
Other Non Operating Income (Expenses)
-15.82-12.31-0.48-0.03-0.2-0.71
EBT Excluding Unusual Items
176.23175.25157.42118.23107.47115.67
Gain (Loss) on Sale of Investments
3.413.41121.44-0.111.7
Gain (Loss) on Sale of Assets
0.010.02-0.17-0.18-0.1-0.18
Asset Writedown
-6.03-6.03----
Other Unusual Items
--2.871.955.591.54
Pretax Income
173.62172.64172.13121.44112.85118.74
Income Tax Expense
23.5523.6626.9312.3318.4218.59
Earnings From Continuing Operations
150.07148.99145.21109.1194.43100.15
Net Income to Company
150.07148.99145.21109.1194.43100.15
Minority Interest in Earnings
1.951.981.223.080.61.22
Net Income
152.02150.97146.42112.295.03101.37
Net Income to Common
152.02150.97146.42112.295.03101.37
Net Income Growth
2.43%3.11%30.50%18.07%-6.26%0.92%
Shares Outstanding (Basic)
136136136135132133
Shares Outstanding (Diluted)
136136136135134133
Shares Change (YoY)
-0.33%0.32%0.29%1.00%0.35%2.25%
EPS (Basic)
1.121.111.080.830.720.76
EPS (Diluted)
1.121.111.080.830.710.76
EPS Growth
2.77%2.78%30.12%16.90%-6.58%-1.30%
Free Cash Flow
186.85186.07170.3447.17-124.91-247.16
Free Cash Flow Per Share
1.381.371.260.35-0.93-1.85
Dividend Per Share
--0.4000.3000.2800.300
Dividend Growth
--33.33%7.14%-6.67%-
Gross Margin
28.83%28.46%27.63%27.07%27.03%26.83%
Operating Margin
14.31%14.05%13.05%11.44%10.54%11.75%
Profit Margin
11.33%11.31%11.29%9.71%8.55%9.73%
Free Cash Flow Margin
13.93%13.94%13.14%4.08%-11.24%-23.71%
EBITDA
319.52310.89276.06200.26180.62162.12
EBITDA Margin
23.82%23.29%21.29%17.33%16.26%15.55%
D&A For EBITDA
127.51123.36106.7968.0663.5839.66
EBIT
192.02187.53169.27132.2117.04122.46
EBIT Margin
14.31%14.05%13.05%11.44%10.54%11.75%
Effective Tax Rate
13.56%13.70%15.64%10.15%16.32%15.65%
Revenue as Reported
--1,2971,1561,1111,042
Advertising Expenses
--1.091.820.390.61
Source: S&P Global Market Intelligence. Standard template. Financial Sources.